Arterial Ischemic Stroke Clinical Trial
Official title:
A Proof of Concept, Phase IIa, Open Label Study to Evaluate the Safety of Afamelanotide in Patients With Acute Arterial Ischaemic Stroke (AIS) Due to Distal [M2 Segment and Beyond] Arterial Large Vessel Occlusion (LVO) or Perforator Occlusion and Who Are Ineligible for Intravenous Thrombolysis (IVT) or Endovascular Thrombectomy (EVT)
The primary study objective is to assess the safety of afamelanotide while the secondary objective is to assess whether the therapy affects the size of the penumbra, by increasing blood flow, restoring oxygen supply to the brain, and reducing the amount of cerebral oedema (fluid) which is seen as a result of the stroke. Positive findings would indicate that the drug is able to support brain tissue-at-risk and provide overall neuroprotection and benefit to stroke patients.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Withdrawn |
NCT03249844 -
Paediatric Arteriopathy Steroid Aspirin Project
|
Phase 3 | |
| Enrolling by invitation |
NCT06040255 -
Focal Cerebral Arteriopathy Steroid Trial
|
Phase 4 | |
| Completed |
NCT03887143 -
National Retrospective Study Of Recanalization Treatments In Pediatric Arterial Ischemic Stroke
|